Ofloxacin and Levofloxacin (Tarivid/Cravit)-Reference-Cited by-同舟云学术

Ofloxacin and Levofloxacin (Tarivid/Cravit)

Published:2019 Issue: Volume: Page:85-110
ISSN:
Container-title:Drug Discovery in Japan
language:
Short-container-title:

Author:

Hara Yasushi,Honjo Yuji

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-13-8906-1_6

Reference51 articles.

1. Baba, S., et al. (1992). Open clinical study on sinusitis of Levofloxacin. Chemotherapy, 40(S3), 365–378.

2. Daichi Sankyo. (2012a). Cravit(R) Development story, born from the solitary flight, Daichi Sankyo R&D Information. http://daiichisankyo.co.jp/rd/newdrug_story/cravit/01/index.html . Accessed April 22, 2012. (in Japanese).

3. Daichi Sankyo. (2012b). Cravit(R) development story, fight with myself, battle with regime, Daichi Sankyo R&D Information. http://daiichisankyo.co.jp/rd/newdrug_story/cravit/02/index.html . Accessed April 22, 2012. (in Japanese).

4. Daiichi Seiyaku. (1997). Daiichi Seiyaku Hachiju-nenshi (in Japanese).

5. Daiichi Seiyaku. (2007). Daiichi Seiyaku Kuju-nenshi (in Japanese).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence and toxicity impact of pharmaceuticals in hospital effluents: Simulation based on a case of study;Process Safety and Environmental Protection;2022-12

2. Discovery and Development of Antibacterial Agents: Fortuitous and Designed;Mini-Reviews in Medicinal Chemistry;2021-12-21

3. Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues;Drug and Chemical Toxicology;2021-10-04

4. Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (Mpro);VirusDisease;2021-07-01